{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:51:40Z","timestamp":1769511100913,"version":"3.49.0"},"reference-count":46,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Foundation for General Practice","award":["File no. A4105"],"award-info":[{"award-number":["File no. A4105"]}]},{"name":"The Foundation for Primary Health Care Research in the Central Denmark Region","award":["File no. 1-30-72-112-16"],"award-info":[{"award-number":["File no. 1-30-72-112-16"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,11]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate temporal trends in the geographical variation in oral anticoagulant (OAC) treatment of patients with atrial fibrillation, to evaluate the extent to which regional differences in patient populations may explain this difference and to explore whether patient predictors of adherence may have a different impact across regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Register-based cohort study from 1 January 2013 to 31 December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study used data from nationwide health registers to explore differences in OAC adherence across the five administrative regions in Denmark.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Patients with atrial fibrillation and a CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score \u22652 (n=291\u2009666).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome<\/jats:title>\n                    <jats:p>Population adherence to OAC treatment operationalised as the proportion of days covered (PDC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A continuous rise in overall adherence (PDC) from 53% to 78% was observed during the study period. Concurrently, the predominant treatment shifted from vitamin K antagonists to direct OACs with a preference for rivaroxaban and apixaban. The adherence variation between the highest-performing and lowest-performing regions decreased from 18% in 2013 to 9% in 2022, whereas the relative between-regions rankings remained unchanged. Applying multivariate Poisson models adjusting for patient demographics, health status and socioeconomic factors did not substantially change the inter-regional variations; this suggests that different compositions of patient populations cannot explain these variations. However, the impact of socioeconomic factors and comorbidities among patients was unequal across regions. In regions with the lowest overall adherence, a higher risk of non-adherence was seen among patients having mental health disorders, low income and living alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The geographical variation in OAC adherence decreased over time as the overall adherence improved. However, substantial variation remained.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-098129","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T21:35:37Z","timestamp":1748122537000},"page":"e098129","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Temporal trends and patient determinants of geographical variation in oral anticoagulant treatment of atrial fibrillation: a Danish nationwide cohort study in 2013\u20132022"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-4032","authenticated-orcid":false,"given":"Ina Gr\u00f8nkj\u00e6r","family":"Laugesen","sequence":"first","affiliation":[{"name":"Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Research Unit for General Practice, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4053-3701","authenticated-orcid":false,"given":"Anders","family":"Prior","sequence":"additional","affiliation":[{"name":"Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Research Unit for General Practice, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"Bro","sequence":"additional","affiliation":[{"name":"Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Research Unit for General Practice, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mygind","sequence":"additional","affiliation":[{"name":"Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Research Unit for General Practice, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-0865","authenticated-orcid":false,"given":"Erik Lerkevang","family":"Grove","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2025121603114703000_15.5.e098129.1","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019897870"},{"key":"2025121603114703000_15.5.e098129.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"2025121603114703000_15.5.e098129.3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2025121603114703000_15.5.e098129.4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"2025121603114703000_15.5.e098129.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"2025121603114703000_15.5.e098129.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034778","article-title":"Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"10","author":"Salmasi","year":"2020","journal-title":"BMJ Open"},{"key":"2025121603114703000_15.5.e098129.7","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab303"},{"key":"2025121603114703000_15.5.e098129.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7370.961"},{"key":"2025121603114703000_15.5.e098129.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d1513","article-title":"Time to tackle unwarranted variations in practice","volume":"342","author":"Wennberg","year":"2011","journal-title":"Bmj"},{"key":"2025121603114703000_15.5.e098129.10","doi-asserted-by":"crossref","unstructured":"Wennberg J , McPherson K , Goodman D . Small area analysis and the challenge of practice variation. Medical Practice Variations 2016;1\u201325. doi:10.1007\/978-1-4899-7573-7_65-1","DOI":"10.1007\/978-1-4899-7573-7_65-1"},{"key":"2025121603114703000_15.5.e098129.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2013.08.002"},{"key":"2025121603114703000_15.5.e098129.12","doi-asserted-by":"publisher","DOI":"10.1177\/1403494815575193"},{"key":"2025121603114703000_15.5.e098129.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.10.001"},{"key":"2025121603114703000_15.5.e098129.14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11239-023-02855-1","article-title":"Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation","volume":"56","author":"Atwater","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"2025121603114703000_15.5.e098129.15","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20210246"},{"key":"2025121603114703000_15.5.e098129.16","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcy011"},{"key":"2025121603114703000_15.5.e098129.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049933","article-title":"Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry","volume":"12","author":"Fox","year":"2022","journal-title":"BMJ Open"},{"key":"2025121603114703000_15.5.e098129.18","doi-asserted-by":"publisher","DOI":"10.1055\/a-2080-6171"},{"key":"2025121603114703000_15.5.e098129.19","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13902"},{"key":"2025121603114703000_15.5.e098129.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-020-5058-1","article-title":"Trends in anticoagulant prescribing: a review of local policies in English primary care","volume":"20","author":"Ho","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2025121603114703000_15.5.e098129.21","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S443473"},{"key":"2025121603114703000_15.5.e098129.22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suab152"},{"key":"2025121603114703000_15.5.e098129.23","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"2025121603114703000_15.5.e098129.24","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394717"},{"key":"2025121603114703000_15.5.e098129.25","unstructured":"Statistics Denmark . Data for research, Available: https:\/\/www.dst.dk\/en\/TilSalg\/Forskningsservice"},{"key":"2025121603114703000_15.5.e098129.26","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"2025121603114703000_15.5.e098129.27","doi-asserted-by":"crossref","first-page":"132098","DOI":"10.1016\/j.ijcard.2024.132098","article-title":"Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013-2021: A nationwide observational study","volume":"408","author":"Madsen","year":"2024","journal-title":"Int J Cardiol"},{"key":"2025121603114703000_15.5.e098129.28","unstructured":"Health TDMo. Healthcare in Denmark - An Overview, Available: www.sum.dk2017"},{"key":"2025121603114703000_15.5.e098129.29","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5490"},{"key":"2025121603114703000_15.5.e098129.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046756","article-title":"Potentially inappropriate medications (PIMs): frequency and extent of GP-related variation in PIMs: a register-based cohort study","volume":"11","author":"Ribe","year":"2021","journal-title":"BMJ Open"},{"key":"2025121603114703000_15.5.e098129.31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M18-0543","article-title":"ESPACOMP Medication Adherence Reporting Guideline (EMERGE)","volume":"169","author":"De Geest","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025121603114703000_15.5.e098129.32","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv324"},{"key":"2025121603114703000_15.5.e098129.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-014-0742-y"},{"key":"2025121603114703000_15.5.e098129.34","doi-asserted-by":"crossref","unstructured":"Laugesen IG , Vestergaard CH , Paust A , et al . General practice-related variation in oral anticoagulant treatment of atrial fibrillation: a nationwide cohort study. BJGP Open 2024. doi:10.3399\/BJGPO.2024.0197","DOI":"10.3399\/BJGPO.2024.0197"},{"key":"2025121603114703000_15.5.e098129.35","unstructured":"Stata Statistical Software: Release 18. [program]. College Station, TX: StataCorp LLC. 2023."},{"key":"2025121603114703000_15.5.e098129.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"2025121603114703000_15.5.e098129.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(01)00201-9"},{"key":"2025121603114703000_15.5.e098129.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.03.212"},{"key":"2025121603114703000_15.5.e098129.39","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1080\/03007995.2018.1459528","article-title":"Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands","volume":"34","author":"Jacobs","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"2025121603114703000_15.5.e098129.40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpsychires.2022.11.002","article-title":"Anticoagulation therapy and outcomes in patients with atrial fibrillation and serious mental illness: A systematic review and meta-analysis","volume":"156","author":"Farran","year":"2022","journal-title":"J Psychiatr Res"},{"key":"2025121603114703000_15.5.e098129.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-024-03373-4","article-title":"Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry","volume":"22","author":"Romiti","year":"2024","journal-title":"BMC Med"},{"key":"2025121603114703000_15.5.e098129.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.06.012"},{"key":"2025121603114703000_15.5.e098129.43","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002544","article-title":"Oral anticoagulation therapy initiation in patients with atrial fibrillation in relation to world region of origin: a register-based nationwide study","volume":"11","author":"Frydenlund","year":"2024","journal-title":"Open Heart"},{"key":"2025121603114703000_15.5.e098129.44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-048839","article-title":"Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study","volume":"11","author":"Lunde","year":"2021","journal-title":"BMJ Open"},{"key":"2025121603114703000_15.5.e098129.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-023-03768-7","article-title":"Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Geriatr"},{"key":"2025121603114703000_15.5.e098129.46","doi-asserted-by":"crossref","DOI":"10.1177\/17539447241290429","article-title":"Challenging anticoagulation decisions in atrial fibrillation: a narrative review","volume":"18","author":"Griffin","year":"2024","journal-title":"Ther Adv Cardiovasc Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-098129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:11:56Z","timestamp":1765883516000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-098129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,24]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2024-098129"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-098129","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}